Advance Zinctek Limited · ASX:ANO
Advance Zinctek — Advance NanoTek — Investor Presentation (December 2019)
17 slides from Advance Zinctek's investor presentation, Dec 20, 2019
Slide 1: Investors Presentation
Advance NanoTek Limited For personal use only ASX: ANO Investors Presentation Team Invest 20 December 2019
Slide 2: Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays
Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays For personal use only “On average, a person’s risk for melanoma doubles if he or she has had more than five sunburns”, (Pfahlberg A, Kölmel KF, Gefeller O. Timing of excessive ultraviolet radiation and melanoma: epidemiolo
Slide 3: Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays
Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays For personal use only ‘hazardous chemical compounds formed as a result of the breakdown of avobenzone, a component of many sunscreen products, when it interacts with chlorinated water and ultraviolet radiation.’ ~ Scientis
Slide 4: Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays
Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays For personal use only ‘Chemicals in sunscreen don’t just sit on top of your skin they absorb into your bloodstream, according to new research from the U.S. Food and Drug Administration’ “Sunscreens have not been subjected
Slide 5: Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays
Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays For personal use only “There are only two effective UVA blockers, one chemical and one mineral (Avobenzone and Zinc Oxide)” -- “Once exposed to the sun, avobenzone alone only offers about 30 minutes of protection.” -- “uns
Slide 6: Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays
Sunscreen Issues when mixed with Chlorinated Water in the Presence of UV Rays For personal use only “Based on the experimental evidence from animal inhalation studies TiO2 nanoparticles are classified as “possible carcinogenic to humans” by the International Agency for Research on Cancer and as occu
Slide 7: It's Personal
It’s Personal For personal use only “31 various skin cancer procedures – For me it’s not just business, it’s PERSONAL” Managing Director Geoff Acton 7
Slide 8: Sales
Company Performance FY17 to now Sales For personal use only • 25 October 2019 Current sales for first 6 months estimated at $11.3 million (FY18: $5.2 million), close to annual sales for FY19, with 175T of orders in the system still to be produced. The total zinc market in 2017 in the US was 550T and
Slide 9: Trading Results
Company Performance FY17 to now Trading Results For personal use only • 16 March 2016 ➢ Appointment of Mr Geoff Acton as Non-executive Director and Managing Director on 2 March 2017. • 29 November 2017 - $0.560 million NPBT ➢ Advance NanoTek Limited continues to improve its trading profitability wit
Slide 10: Powder Production / Sales
Company Performance FY17 to now Powder Production / Sales For personal use only • 22 March 2017 ➢ Pre-curser raw material shortage will be rectified by 1st week of April of 2017 when 24 tonnes arrives in the warehouse and we currently have approximately $900,000 of sales orders ready to invoice and
Slide 11: Powder Production / Sales
Company Performance FY17 to now Powder Production / Sales For personal use only • 19 September 2018 ➢ We have witnessed a significant increase in forward sales orders for ZinClear and ZinClear XP from now until the end of November 2018 that is in excess of 50% above our sales revenue for the corresp
Slide 12: Powder Production / Sales
Company Performance FY17 to now Powder Production / Sales For personal use only • 22 February 2019 ➢ Current production of 15T per week (from 7T per week FY17). ➢ Lift production to increase of 31T per week from 1 May 2019 (estimated). ➢ Lift production to 40T in late 2019, annual capacity of 2,200T
Slide 13: Powder Production / Sales
Company Performance FY17 to now Powder Production / Sales For personal use only • 25 October 2019 ➢ We currently see no reason why the Company will not achieve its current forecasts with in excess of 225T of future sales orders yet to be manufactured, right now. • 15 November 2019 ➢ Orders for US $5
Slide 14: Merck KGaA
Company Performance FY17 to now Merck KGaA For personal use only • 22 December 2016 ➢ It anticipates sales of between 15 and 20 tonnes of Alusion™ for calendar year 2017. • 15 September 2017 ➢ The Board expects an increase in Alusion sales of in excess of 80% for FY18, FY17 sales of $450,000, and al
Slide 15: Unfinished Business
Company Performance FY17 to now Unfinished Business For personal use only • 17 January 2017 ➢ Outsourced manufacturing agreement of ZinClear and end formulations signed. • 21 September 2017 ➢ 3D printing using our materials. • 18 September 2017 ➢ The production equipment in question comprise mostly
Slide 16: ASX Queries
Company Performance FY17 to now ASX Queries For personal use only • 14 March 2019 ➢ ANO formal price query response. • 27 May 2019 ➢ ANO formal response to aware query. • 12 July 2019 ➢ ANO formal price query response. • 19 August 2019 ➢ The Board would like to confirm that the Investor Presentation
Slide 17: Disclaimer
Disclaimer For personal use only Management of Advance NanoTek Ltd (ABN 54 079 845 855) and its subsidiaries (collectively ‘ANO’) has made every effort to ensure the accuracy of the information contained in this presentation. The presentation has been prepared based on information available prior to
Advance NanoTek — Investor Presentation (December 2019) on 6ix